26 Feb 2017 | 9:38 PM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
430.05
-4.50
(-1.03 %)
23 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    434.00
  • Prev. close (Rs.)
    434.55
  • High (Rs.)
    439.40
  • Low (Rs.)
    427.10
  • 52W H (Rs.)
    460.00
  • 52W L (Rs.)
    305.00
  • Volume (Rs.)
    149666
  • MCap (Rs in Cr.)
    44,026.07
434
0.05
(0.01 %)
  • Open (Rs)
    433.70
  • High (Rs)
    440.00
  • Low (Rs)
    428.10
  • Prev. close(Rs)
    433.95
  • Contracts Tra.
    29,15,200
  • Turnover (Cr.)
    126
  • Open Interest
    31,39,200
  • Open Int. chg
    9,37,600.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
14.87
Operating Margin (%)
24.22
Gross Profit Margin (%)
21.15
Net Profit Margin (%)
15.47
Total Debt/Equity
0.39
Dividend payout Ratio (Net Profit)
25.89
Earning Retention Ratio
74.65

News

23 Feb 2017 - 17:03:00-Drug firm Zydus Cadila today said the US health regulator has approved the group's plans to init...
17 Feb 2017 - 13:49:00-Pharma major Cadila Healthcare Ltd on Friday said that Zydus Cadila has received final approval from...
16 Feb 2017 - 16:16:00-Drug firm Cadila Healthcare today said the US health regulator has inspected the company's Morai...
31 Jan 2017 - 16:05:00-Pharma giant Cadila Healthcare Ltd on Tuesday suffered a setback in the October-December quarter and...

Announcements

24-Feb-2017
Cadila Healthcar - Zydus Cadila to launch India`s 1st Tetravalent Inactivated Influenza vaccine - VaxiFlu - 4
24-Feb-2017
Cadila Healthcar - Zydus Cadila to launch Indias 1st Tetravalent Inactivated Influenza vaccine - VaxiFlu - 4
23-Feb-2017
Cadila Healthcar - Tribunal Convened Meeting on March 30 2017
23-Feb-2017
Cadila Healthcar - Zydus receives approval from USFDA to initiate Phase II clinical studies of Saroglitazar Magnesium in pati
21-Feb-2017
Cadila Healthcar - Investor Presentation

Religare Research

23 Feb 2017 | 06:00 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
23 Feb 2017 | 06:00 PM
Nifty index settled on a positive note for the fifth successive week, hitting 52 week high on the la...
23 Feb 2017 | 12:45 PM
VIP Industries (VIP) reported in-line numbers for Q3FY17 with a revenue and PAT growth of 5.5% & 43....
23 Feb 2017 | 11:15 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,405 189.90 76.07 -0.11
10,00,405 189.90 30.97 -0.11
10,00,405 189.90 76.07 -0.11
10,00,405 189.90 20.24 -0.11
10,00,405 189.90 78.51 -0.11

Shareholding Pattern

       
Promotors74.79%
Mutual Funds/UTI3.46%
FI/Banks3.65%
Insurance3.65%
FII9.96%
Government0.11%
Others2.78%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,890.15(-0.31)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,660.10(-0.52)
3317
 Alkem Laboratories Ltd.
2,073.85(2.55)
17141
 Piramal Enterprises Ltd.
1,866.45(-1.66)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Cadila Healthcare Ltd.73.0038.0058.35
NIFTY(S&P CNX)548.00906.20306.90
BSE SENSEX1,775.632,841.16902.76
BSE 500763.721,333.78587.62

Corporate Details

Key Personal
No Data Available
Key Address
Registered Office
Zydus Tower Satellite Cross Roads Sarkhej Gandhinagar Highway,Ahmedabad,Gujarat

Tel:079-26868100, Fax:079-26862365 26862366

investor.grievance@zyduscadila.com
http://www.zyduscadila.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :44 Community Center 2nd Floor Naraina Industrial Area Phase I Near PVR Naraina

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Cadila Healthcare Ltd. that will help you decide whether to buy, sell or hold Cadila Healthcare Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Cadila Healthcare Ltd.